Annual Net Income
-$83.99 M
+$45.99 M+35.38%
31 December 2023
Summary:
Amneal Pharmaceuticals annual net profit is currently -$83.99 million, with the most recent change of +$45.99 million (+35.38%) on 31 December 2023. During the last 3 years, it has fallen by -$175.05 million (-192.24%). AMRX annual net income is now -140.50% below its all-time high of $207.38 million, reached on 31 December 2016.AMRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$156.00 K
-$6.15 M-102.60%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly net profit is currently -$156.00 thousand, with the most recent change of -$6.15 million (-102.60%) on 30 September 2024. Over the past year, it has dropped by -$9.84 million (-101.61%). AMRX quarterly net income is now -100.14% below its all-time high of $115.07 million, reached on 31 March 2020.AMRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$184.45 M
-$9.84 M-5.63%
30 September 2024
Summary:
Amneal Pharmaceuticals TTM net profit is currently -$184.45 million, with the most recent change of -$9.84 million (-5.63%) on 30 September 2024. Over the past year, it has dropped by -$194.78 million (-1886.83%). AMRX TTM net income is now -204.02% below its all-time high of $177.33 million, reached on 31 March 2018.AMRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.4% | -101.6% | -1886.8% |
| 3 y3 years | -192.2% | +96.3% | -1420.9% |
| 5 y5 years | +50.5% | +99.9% | +45.5% |
AMRX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -192.2% | +35.4% | -101.3% | +99.9% | -1420.9% | at low |
| 5 y | 5 years | -192.2% | +76.8% | -100.1% | +99.9% | -302.6% | +49.0% |
| alltime | all time | -140.5% | +76.8% | -100.1% | +99.9% | -204.0% | +49.0% |
Amneal Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$156.00 K(-102.6%) | -$184.45 M(+5.6%) |
| June 2024 | - | $5.99 M(-106.5%) | -$174.62 M(+3.5%) |
| Mar 2024 | - | -$91.64 M(-7.1%) | -$168.69 M(+100.8%) |
| Dec 2023 | -$83.99 M(-35.4%) | -$98.65 M(-1118.9%) | -$83.99 M(-913.6%) |
| Sept 2023 | - | $9.68 M(-18.8%) | $10.32 M(-604.1%) |
| June 2023 | - | $11.92 M(-271.6%) | -$2.05 M(-98.5%) |
| Mar 2023 | - | -$6.94 M(+60.2%) | -$134.77 M(+3.7%) |
| Dec 2022 | -$129.99 M(-1323.5%) | -$4.33 M(+61.1%) | -$129.99 M(-1.5%) |
| Sept 2022 | - | -$2.69 M(-97.8%) | -$132.03 M(-1.2%) |
| June 2022 | - | -$120.81 M(+5503.3%) | -$133.58 M(-7681.0%) |
| Mar 2022 | - | -$2.16 M(-66.2%) | $1.76 M(-83.4%) |
| Dec 2021 | $10.62 M(-88.3%) | -$6.38 M(+50.5%) | $10.62 M(-23.9%) |
| Sept 2021 | - | -$4.24 M(-129.2%) | $13.96 M(+51.4%) |
| June 2021 | - | $14.53 M(+116.7%) | $9.23 M(-153.3%) |
| Mar 2021 | - | $6.71 M(-320.8%) | -$17.30 M(-119.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $91.06 M(-125.2%) | -$3.04 M(-66.2%) | $91.06 M(+46.9%) |
| Sept 2020 | - | -$8.97 M(-25.2%) | $61.97 M(-131.9%) |
| June 2020 | - | -$12.00 M(-110.4%) | -$194.06 M(-2.5%) |
| Mar 2020 | - | $115.07 M(-458.2%) | -$198.97 M(-45.0%) |
| Dec 2019 | -$361.92 M(+113.2%) | -$32.13 M(-87.9%) | -$361.92 M(+6.9%) |
| Sept 2019 | - | -$265.01 M(+1467.9%) | -$338.56 M(+408.4%) |
| June 2019 | - | -$16.90 M(-64.7%) | -$66.60 M(-75.3%) |
| Mar 2019 | - | -$47.88 M(+446.1%) | -$269.14 M(+58.6%) |
| Dec 2018 | -$169.73 M(-201.2%) | -$8.77 M(-226.1%) | -$169.73 M(+70.8%) |
| Sept 2018 | - | $6.95 M(-103.2%) | -$99.39 M(+24.9%) |
| June 2018 | - | -$219.44 M(-525.8%) | -$79.56 M(-144.9%) |
| Mar 2018 | - | $51.53 M(-16.3%) | $177.33 M(+41.0%) |
| Dec 2017 | $167.65 M(-19.2%) | $61.57 M(+129.9%) | $125.80 M(+95.9%) |
| Sept 2017 | - | $26.78 M(-28.5%) | $64.23 M(+71.5%) |
| June 2017 | - | $37.45 M | $37.45 M |
| Dec 2016 | $207.38 M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual net profit?
- What is the all time high annual net income for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual net income year-on-year change?
- What is Amneal Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly net income year-on-year change?
- What is Amneal Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM net income year-on-year change?
What is Amneal Pharmaceuticals annual net profit?
The current annual net income of AMRX is -$83.99 M
What is the all time high annual net income for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual net profit is $207.38 M
What is Amneal Pharmaceuticals annual net income year-on-year change?
Over the past year, AMRX annual net profit has changed by +$45.99 M (+35.38%)
What is Amneal Pharmaceuticals quarterly net profit?
The current quarterly net income of AMRX is -$156.00 K
What is the all time high quarterly net income for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly net profit is $115.07 M
What is Amneal Pharmaceuticals quarterly net income year-on-year change?
Over the past year, AMRX quarterly net profit has changed by -$9.84 M (-101.61%)
What is Amneal Pharmaceuticals TTM net profit?
The current TTM net income of AMRX is -$184.45 M
What is the all time high TTM net income for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM net profit is $177.33 M
What is Amneal Pharmaceuticals TTM net income year-on-year change?
Over the past year, AMRX TTM net profit has changed by -$194.78 M (-1886.83%)